INCY  valuation analysis

Basics
Name: Incyte Corporation
Description: Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 08, 2022
Market cap: $16.52B (392nd)
Sales(TTM): $2.99B (669th)
Earnings(TTM): $948.58M (337th)

Value
FFER: 1.16*
Actual price: $74.35
* Earnings were reported May 02, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-03-17
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Incyte Corporation's earnings increased from -$295.70M to $948.58M in the last year.
  • Incyte Corporation's operating income increased from -$240.31M to $572.73M in the last year.
Earnings / MarketCap
Incyte Corporation
"Biotechnology" industry
Sales / MarketCap
Incyte Corporation
"Biotechnology" industry
Book / MarketCap
Incyte Corporation
"Biotechnology" industry
Equity / Assets
Incyte Corporation
"Biotechnology" industry